Legend Financial Statements From 2010 to 2023

LEGN Stock  USD 63.38  0.24  0.38%   
Legend BiotechCorp financial statements provide useful quarterly and yearly information to potential Legend BiotechCorp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Legend BiotechCorp financial statements helps investors assess Legend BiotechCorp's valuation, profitability, and current liquidity needs.
We have found seventy-six available fundamental ratios for Legend BiotechCorp, which can be analyzed and compared to other ratios and to its peers in the industry. Make sure you check Legend BiotechCorp's last-minute fundamentals against the trend between 2010 and 2023 to make sure the company can sustain itself down the road.
Legend BiotechCorp Average Equity is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Average Equity of 755.13 Million. As of 3rd of June 2023, Invested Capital is likely to grow to about 511.7 M, while Average Assets are likely to drop about 1.1 B.
  
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Cost of Revenue of 58.5 M, Gross Profit of 62.4 M or Interest Expense of 11.6 M, as well as many exotic indicators such as Asset Turnover of 0.1, Book Value per Share of 4.09 or Current Ratio of 3.7. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules. It can also supplement Legend BiotechCorp's financial leverage analysis and stock options assessment as well as various Legend BiotechCorp Technical models . Check out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Legend BiotechCorp Revenues

104.42 Million

Legend BiotechCorp Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Tax Liabilities10 M9.8 M51.4 M
Slightly volatile
Tax Assets61.7 M62 M67.9 M
Slightly volatile
Trade and Non Trade Receivables92.4 K90 K28 M
Very volatile
Property Plant and Equipment Net146.4 M160.8 M66.8 M
Slightly volatile
Trade and Non Trade Payables181 M217 M79.2 M
Slightly volatile
Liabilities Non Current256.2 M288.9 M255.9 M
Pretty Stable
Current Liabilities269.6 M297.8 M179.9 M
Slightly volatile
Total Liabilities564.9 M586.7 M438.6 M
Slightly volatile
Investments Non Current4.2 M4.2 M4.6 M
Slightly volatile
Investments Current201.6 M186.9 M34.1 M
Slightly volatile
Investments201.6 M186.9 M34.4 M
Slightly volatile
Inventory11.2 M10.4 M2.6 M
Slightly volatile
Goodwill and Intangible Assets3.1 M3.4 M1.1 M
Slightly volatile
Shareholders Equity USD803.1 M744.3 M182 M
Slightly volatile
Shareholders Equity Attributable to Parent803.1 M744.3 M182 M
Slightly volatile
Deferred Revenue383.5 M379.6 M316.1 M
Slightly volatile
Total Debt USD307 M284.5 M54.5 M
Slightly volatile
Debt Non Current303.2 M281 M53.5 M
Slightly volatile
Debt Current3.8 M3.6 MM
Slightly volatile
Total Debt307 M284.5 M54.5 M
Slightly volatile
Cash and Equivalents USD739.4 M840 M356.3 M
Slightly volatile
Cash and Equivalents739.4 M840 M356.3 M
Slightly volatile
Assets Non Current204.5 M231.8 M123.8 M
Slightly volatile
Current Assets946.2 M1.1 B481.3 M
Slightly volatile
Total Assets1.2 B1.3 B605.1 M
Slightly volatile

Legend BiotechCorp Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Income Tax Expense674.3 K625 K(4.2 M)
Slightly volatile
Weighted Average Shares Diluted317.4 M318.1 M225.2 M
Slightly volatile
Weighted Average Shares317.4 M318.1 M225.2 M
Slightly volatile
Selling General and Administrative Expense141.7 M174 M43.3 M
Slightly volatile
Research and Development Expense304.5 M335.6 M135.2 M
Slightly volatile
Revenues USD104.4 M117 M62 M
Slightly volatile
Revenues104.4 M117 M62 M
Slightly volatile
Operating Expenses434.9 M497.6 M166.7 M
Slightly volatile
Interest Expense11.6 M10.8 MM
Slightly volatile
Gross Profit62.4 M51.6 M54.3 M
Slightly volatile
Cost of Revenue58.5 M58.8 M64.4 M
Slightly volatile

Legend BiotechCorp Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Share Based Compensation37 M34.3 M7.4 M
Slightly volatile
Effect of Exchange Rate Changes on Cash (2.6 M)(2.5 M)(219.1 K)
Slightly volatile
Net Cash Flow from Operations(215.6 M)(210 M)129.9 M
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals(43.2 M)(40 M)(23.7 M)
Slightly volatile
Net Cash Flow from Financing388.9 M378 M146.4 M
Slightly volatile
Issuance Repayment of Debt Securities (2.7 M)(2.6 M)M
Pretty Stable
Issuance Purchase of Equity Shares406.9 M380.6 M465.3 M
Very volatile
Net Cash Flow Business Acquisitions and Disposals(16 M)(14.8 M)(49.2 M)
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents143.4 M99.6 M185.2 M
Pretty Stable
Depreciation Amortization and Accretion15.4 M18.4 M5.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Tangible Assets Book Value per Share8.048.3474.2215
Slightly volatile
Sales per Share0.750.7360.6147
Slightly volatile
Return on Average Equity(0.64)(0.591)0.8662
Slightly volatile
Price to Sales Ratio75.7867.85551.9286
Slightly volatile
Price to Book Value9.9610.35212.2948
Slightly volatile
Gross Margin0.610.4410.9319
Slightly volatile
EBITDA Margin(3.84)(3.56)(1.3592)
Slightly volatile
Debt to Equity Ratio0.810.78831.2681
Slightly volatile
Current Ratio3.73.6912.523
Slightly volatile
Book Value per Share4.094.680.3068
Slightly volatile
Asset Turnover0.10.0950.1496
Slightly volatile

Legend BiotechCorp Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Working Capital676.6 M801.3 M301.4 M
Slightly volatile
Tangible Asset Value1.1 B1.3 B604 M
Slightly volatile
Market Capitalization7.6 B7.7 B4.4 B
Slightly volatile
Invested Capital Average340.1 M315.2 M77.4 M
Slightly volatile
Invested Capital511.7 M474.3 M127.1 M
Slightly volatile
Free Cash Flow(237 M)(231 M)106.6 M
Slightly volatile
Enterprise ValueB7.2 B3.9 B
Slightly volatile
Average Equity814.7 M755.1 M104.4 M
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD(427.5 M)(416.5 M)(117.9 M)
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(427.5 M)(416.5 M)(117.9 M)
Slightly volatile
Average Assets1.1 B1.2 B517.2 M
Slightly volatile

Legend Fundamental Market Drivers

Cash And Short Term InvestmentsB

Legend Upcoming Events

16th of February 2024
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
31st of March 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Legend BiotechCorp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Deferred Revenue379.6 M383.5 M
Cost of Revenue58.8 M58.5 M
Revenues117 M104.4 M

Legend BiotechCorp Investors Sentiment

The influence of Legend BiotechCorp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Legend. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend BiotechCorp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend BiotechCorp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Legend BiotechCorp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Legend BiotechCorp.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Legend BiotechCorp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Legend BiotechCorp's short interest history, or implied volatility extrapolated from Legend BiotechCorp options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEO Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.26) 
Revenue Per Share
0.639
Quarterly Revenue Growth
(0.12) 
Return On Assets
(0.29) 
Return On Equity
(0.96) 
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.